We provide independent, institution-grade, buyside research analysis. Why buyside? Because our work is written by investors, for investors. We're a pureplay research business. We don't sell securities, nor advise on capital raising, M&A, IPOs, or restructuring, we don't manage institutional money and we don't source capital for funds.
Our 100% focus is investment research, paid for by our subscribers, not by sponsors or securities issuers. This is why our work is different.
Being different extends to our team. In an age of automation we don't need an army of graduate trainees. Machines can do most of what an investment bank analyst class used to do. Our work is produced by experienced investors from across the securities landscape.
Our focus is the US equity market, but in order to understand equities you have to understand how they are driven by Federal Reserve actions, by the rates market, by the options market, and by the ebbs and flows of institutional accumulation and distribution. With that in mind, we've built a team of experienced investors who understand how markets work and why.
Fundamental & technical stock analysis. Three-decade professional technology investor. Founder & CEO of Cestrian Capital Research, Inc.
Federal Reserve policy analysis; policy impact on US stocks, bonds & bond ETFs. Founder-CEO at Plantwise, Inc. Former institutional rates trader.
Proprietary options market analysis; options market impact on US stock indices; single-stock options strategies.
ETF & single-stock technical analysis. Senior pharmaceutical research scientist by day.
Fundamental bond- and options market analysis.
Copyright © 2020 Cestrian Capital Research, Inc - All Rights Reserved.
This website uses cookies. By continuing to use this site, you accept our use of cookies.